Retatrutide, developed by Soma Corp., is attracting considerable attention as a innovative therapy for weight control . This dual-action medication combines the mechanism of a GLP-1 receptor check here stimulant and a GIP receptor agonist , intended to effectively promote reduced body fat but also improve associated metabolic issues . Initial patie